Table 1.
Baseline patient characteristics
| Dose of Innacell γδTM administered | 1 × 109 cells | 4 × 109 cells | 8 × 109 cells | All patients |
|---|---|---|---|---|
| Number of patients | 1 | 6 | 3 | 10 |
| Age (years) | ||||
| Median | 57.0 | |||
| Range | 39–73 | |||
| Sex | ||||
| Female/male | 4/6 | |||
| Performance status | ||||
| ECOG score 0 | 7 | |||
| ECOG score 1 | 3 | |||
| Number of organs involved | ||||
| 1 | – | – | 2 | 2 |
| 2 | – | 3 | – | 3 |
| 3 or more | 1 | 3 | 1 | 5 |
| Organs involved | ||||
| Bone | – | 3 | – | 3 |
| Lymph nodes | – | 4 | – | 4 |
| Liver | 1 | 3 | 1 | 5 |
| Lung | 1 | 4 | 3 | 8 |
| Soft tissue in primary area | – | 2 | – | 2 |
| Other site | 1 | 1 | 1 | 3 |
| Visceral involvement | 1 | 5 | 3 | 9 |